Read more about Intas Pharma files draft prospectus for IPO on Business Standard. Drug maker Intas Pharmaceuticals today said it has filed. Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with Securities and Exchange Board of India (SEBI) for an initial public. Intas Pharma DRHP News: Latest and Breaking News on Intas Pharma DRHP. Explore Intas Pharma DRHP profile at Times of India for photos, videos and latest .
|Published (Last):||13 November 2005|
|PDF File Size:||13.8 Mb|
|ePub File Size:||9.67 Mb|
|Price:||Free* [*Free Regsitration Required]|
Mon, Dec 31, Updated Nimish Hasmukhbhai Chudgar, Dr. According to sources, the company has begun the groundwork for the IPO and approached merchant bankers a couple of months ago. Monday, 31 December Visit Our Digital Magazine: Desi pharma companies top in biosimilars globally.
All rights reserved Disclaimer. Intas Pharma merges group companies, subsidiaries. Intas Intad files for an IPO.
Intas Pharma files draft prospectus for IPO
ChrysCap backs Curatio in latest pharma bet. The promoters of the company are Mr. In what could further strengthen its business in European and non-European countries, Ahmedabad based Intas Pharmaceuticals Ltd has acquired hospital business of Combino Pharm in Spain and Portugal for an undisclosed sum. The Ahmedabad-based company is considering licensing agreements with hospital-based businesses in these markets.
Email Enter a valid email address. The IPO will be made through a public issue of equity shares of face value of Rs. At present, domestic companies are marketing their products only in emerging markets, but intxs largest and most lucrative market for all pharmaceuticals — the US — is the next stop.
Intas Pharma DRHP: Latest News, Videos and Photos of Intas Pharma DRHP | Times of India
MCI to drph foreign jaunts by MP doctors. Intas to buy Teva’s UK, Ireland assets for mn pounds. The company is present in various major therapy areas such as those relating to neurology, psychiatry, cardiology, pain management, gastroenterology, diabetology, nephrology, urology, anti-infective therapy, dermatology, gynecology, respiratory system, oncology, critical care and ophthalmology with a strong focus on chronic therapy areas relating to neurology, psychiatry, cardiology and diabetology.
Chandra kicks off divestment plan.
Intas Pharma buys Spanish company’s hospital business. Intas Pharma launches first etanercept biosimilar.
It has also extended its presence into other therapy areas such as gynecology, infertility, arthritis and the respiratory. Medical Council of India MCI will investigate a complaint against 11 doctors from Madhya Pradesh who are charged with accepting foreign jaunts sponsored by pharmaceutical company. Rahul Gandhi listed as ‘non-Hindu’.
Sun Pharma in early talks to buy Intas Pharma. Hyderabad-based pharma giant Aurobindo snaps up Portuguese co for Rs crore.
We will get in touch with you shortly. Please note that comments are moderated inyas are generally published if they are on-topic and not abusive.
Intas Pharmaceuticals files DRHP for IPO
Web Interface Conceived and Powered By: Subscribe to BioSpectrum India. Please click here to Sign-in or Sign-up.
Sources said the group has started a process to sell drug discovery services drph Advinus Therapeutics, drawing interest from private equity funds Kedaara Capital and True North as well as from strategic players, GVK Biosciences and Lambda, a unit of Intas Pharma.
Please fill the all fields. Enquiry Thanks for contacting us! Intas Pharma is a vertically integrated Indian pharmaceutical company with global operations, engaged in the development, manufacture and marketing of pharmaceutical formulation. Binish Hasmukh Chudgar, Mr.